Lina Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lina Zhang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Wuxiong Zhou
Institute of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
3 shared publicationsXiaolan Lian
Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
3 shared publicationsYongpin Dong
Institute of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
3 shared publicationsChunni Guo
Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publicationsMingyi Zhao
Department of Pediatrics, Third Xiangya Hospital of Central South University, Hunan, China
2 shared publicationsWenfang Li
Changzheng Hospital
2 shared publications
Latest Publications
- RetractionOpen Access
- 28 February 2023
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 14 (1) , 1
Retraction Note: Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs
- 28 February 2023
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 14 (1) , 1
RetractionOpen AccessRetraction Note: Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs
- RetractedOpen Access
- 9 August 2021
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 12 (1) , 1-17
RETRACTED ARTICLE: Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs
Background: Age-associated changes attenuate human blood system functionality through the aging of hematopoietic stem and progenitor cells (HSPCs), manifested in human populations an increase in myeloproliferative disease and even leukemia; therefore, study on HSPC senescence bears great significance to treat hematopoietic-associated disease. Furthermore, the mechanism of HSPC aging is lacking, especially the cellular memory mechanism. Here, we not only reported a new HSPC senescence model in vitro, but also propose and verify the cellular memory mechanism of HSPC aging of the Polycomb/Trithorax system. Methods: HSPCs (Lin−c-kit+ cells) were isolated and purified by magnetic cell sorting (MACS). The proportions and cell cycle distribution of cells were determined by flow cytometry; senescence-related β-galactosidase assay, transmission electron microscope (TEM), and colony-forming unit (CFU)-mix assay were detected for identification of the old HSPC model. Proteomic tests and RNA-seq were applied to analyze differential pathways and genes in the model cells. qPCR, Western blot (WB), and chromatin immunoprecipitation PCR (CHIP-PCR) were used to detect the gene expression of cell memory-related proteins. Knockdown of cell memory-related key genes was performed with shRNA interference. Results: In the model old HSPCs, β-gal activity, cell cycle, colony-forming ability, aging-related cell morphology, and metabolic pathway were significantly changed compared to the young HSPCs. Furthermore, we found the model HSPCs have more obvious aging manifestations than those of natural mice, and IL3 is the major factor contributing to HSPC aging in the model. We also observed dramatic changes in the expression level of PRC/TrxG complexes. After further exploring the downstream molecules of PRC/TrxG complexes, we found that Uhrf1 and TopII played critical roles in HSPC aging based on the HSPC senescence model. Conclusions: These findings proposed a new HSPC senescence model in vitro which we forecasted could be used to preliminary screen the drugs of the HSPC aging-related hemopathy and suggested cellular memory mechanism of HSPC aging.
- 9 August 2021
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 12 (1) , 1-17
RetractedOpen AccessRETRACTED ARTICLE: Using a new HSPC senescence model in vitro to explore the mechanism of cellular memory in aging HSPCs
Background: Age-associated changes attenuate human blood system functionality through the aging of hematopoietic stem and progenitor cells (HSPCs), manifested in human populations an increase in myeloproliferative disease and even leukemia; therefore, study on HSPC senescence bears great significance to treat hematopoietic-associated disease. Furthermore, the mechanism of HSPC aging is lacking, especially the cellular memory mechanism. Here, we not only reported a new HSPC senescence model in vitro, but also propose and verify the cellular memory mechanism of HSPC aging of the Polycomb/Trithorax system. Methods: HSPCs (Lin−c-kit+ cells) were isolated and purified by magnetic cell sorting (MACS). The proportions and cell cycle distribution of cells were determined by flow cytometry; senescence-related β-galactosidase assay, transmission electron microscope (TEM), and colony-forming unit (CFU)-mix assay were detected for identification of the old HSPC model. Proteomic tests and RNA-seq were applied to analyze differential pathways and genes in the model cells. qPCR, Western blot (WB), and chromatin immunoprecipitation PCR (CHIP-PCR) were used to detect the gene expression of cell memory-related proteins. Knockdown of cell memory-related key genes was performed with shRNA interference. Results: In the model old HSPCs, β-gal activity, cell cycle, colony-forming ability, aging-related cell morphology, and metabolic pathway were significantly changed compared to the young HSPCs. Furthermore, we found the model HSPCs have more obvious aging manifestations than those of natural mice, and IL3 is the major factor contributing to HSPC aging in the model. We also observed dramatic changes in the expression level of PRC/TrxG complexes. After further exploring the downstream molecules of PRC/TrxG complexes, we found that Uhrf1 and TopII played critical roles in HSPC aging based on the HSPC senescence model. Conclusions: These findings proposed a new HSPC senescence model in vitro which we forecasted could be used to preliminary screen the drugs of the HSPC aging-related hemopathy and suggested cellular memory mechanism of HSPC aging.
- Open Access
- 30 March 2021
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 20 (1) , 125-130
Mannotriose induced differentiation of mesenchymal stem cells into neuron-like cells
This article demonstrates that mannotriose effectively induces the differentiation of mesenchymal stem cells into neuron-like cells in vitro. Rat-derived mesenchymal stem cells were investigated on their potential to differentiate into neuron-like cells induced by mannotriose purified from Radix Rehmanniae Preparata in vitro. The percentage of the neuron-specific enolase positive cells and the Nissl positive cells after mannotriose treatment was increased. The mRNA levels of neurofilament medium and neuron-specific enolase were upregulated in the mannotriose group compared to the control. These findings demonstrate that mannotriose purified from Radix Rehmanniae Preparata can effectively induce differentiation of rat-derived mesenchymal stem cells into neuron-like cells.
- 30 March 2021
- Published by IMR Press in Journal of Integrative Neuroscience
- Vol. 20 (1) , 125-130
Open AccessMannotriose induced differentiation of mesenchymal stem cells into neuron-like cells
This article demonstrates that mannotriose effectively induces the differentiation of mesenchymal stem cells into neuron-like cells in vitro. Rat-derived mesenchymal stem cells were investigated on their potential to differentiate into neuron-like cells induced by mannotriose purified from Radix Rehmanniae Preparata in vitro. The percentage of the neuron-specific enolase positive cells and the Nissl positive cells after mannotriose treatment was increased. The mRNA levels of neurofilament medium and neuron-specific enolase were upregulated in the mannotriose group compared to the control. These findings demonstrate that mannotriose purified from Radix Rehmanniae Preparata can effectively induce differentiation of rat-derived mesenchymal stem cells into neuron-like cells.
- Open Access
- 25 February 2021
- Published by Springer Nature in Research Square
Using a new HSPC aging model in vitro to explore the mechanism of cellular memory in aging HSPCs
Age-associated changes attenuate human blood system functionality through the aging of hematopoietic stem and progenitor cells (HSPCs). Hematopoietic aging is manifested in human populations in the form of an increase in myeloproliferative disease,therefore, study on hematopoietic stem and progenitor cells (HSPCs) senescence bears great significance to treat hematopoietic associated disease. However, the mechanism of HSPC aging is lacking, especially cellular memory mechanism. Here, we not only reported a new HSPC aging model in vitro, but also propose and verify the cellular memory mechanism of HSPC aging of Polycomb/Trithorax system. In this model cells, the senescence-related β-gal activity, cell cycle, colony-forming ability, aging-related cell morphology and metabolic pathway are significantly changed compare to the young group. Furthermore, we found the model HSPCs have more obvious aging manifestation than those of natural mice and IL3 is the major factor contributing to HSPC aging in the model. We also observed dramatically changes in the expression level of PRC/TrxG complexes. We further identified downstream molecules of PRC/TrxG complexes,Uhrf1 and TopII, which were found to play a critical role in HSPC aging based on the HSPC aging model. So, these findings proposed a new aging HSPC model in vitro which we forecasted could be used to preliminary screen the drugs of the HSPC aging related hemopathy and suggested cellular memory mechanism of HSPC aging.
- 25 February 2021
- Published by Springer Nature in Research Square
Open AccessUsing a new HSPC aging model in vitro to explore the mechanism of cellular memory in aging HSPCs
Age-associated changes attenuate human blood system functionality through the aging of hematopoietic stem and progenitor cells (HSPCs). Hematopoietic aging is manifested in human populations in the form of an increase in myeloproliferative disease,therefore, study on hematopoietic stem and progenitor cells (HSPCs) senescence bears great significance to treat hematopoietic associated disease. However, the mechanism of HSPC aging is lacking, especially cellular memory mechanism. Here, we not only reported a new HSPC aging model in vitro, but also propose and verify the cellular memory mechanism of HSPC aging of Polycomb/Trithorax system. In this model cells, the senescence-related β-gal activity, cell cycle, colony-forming ability, aging-related cell morphology and metabolic pathway are significantly changed compare to the young group. Furthermore, we found the model HSPCs have more obvious aging manifestation than those of natural mice and IL3 is the major factor contributing to HSPC aging in the model. We also observed dramatically changes in the expression level of PRC/TrxG complexes. We further identified downstream molecules of PRC/TrxG complexes,Uhrf1 and TopII, which were found to play a critical role in HSPC aging based on the HSPC aging model. So, these findings proposed a new aging HSPC model in vitro which we forecasted could be used to preliminary screen the drugs of the HSPC aging related hemopathy and suggested cellular memory mechanism of HSPC aging.
- 5 March 2020
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 33 (11) , 3123-3134
Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomic analysis of mRNA splicing relevant proteins in aging HSPCs
Background HSPC (hematopoietic stem/progenitor cell) aging was closely associated with the organism aging, senile diseases and hematopoietic related diseases. Therefore, study on HSPC aging is of great significance to further elucidate the mechanisms of aging and to treat hematopoietic disease resulting from HSPC aging. Little attention had been paid to mRNA splicing as a mechanism underlying HSPC senescence. Results We used our lab’s patented in vitro aging model of HSPCs to analyze mRNA splicing relevant protein alterations with iTRAQ-based proteomic analysis. We found that not only the notable mRNA splicing genes such as SR, hnRNP, WBP11, Sf3b1, Ptbp1 and U2AF1 but also the scarcely reported mRNA splicing relevant genes such as Rbmxl1, Dhx16, Pcbp2, Pabpc1 were significantly down-regulated. We further verified their gene expressions by qRT-PCR. In addition, we reported the effect of Spliceostatin A (SSA), which inhibits mRNA splicing in vivo and in vitro, on HSPC aging. Conclusions It was concluded that mRNA splicing emerged as an important factor for the vulnerability of HSPC aging. This study improved our understanding of the role of mRNA splicing in the HSPC aging process.
- 5 March 2020
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 33 (11) , 3123-3134
Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomic analysis of mRNA splicing relevant proteins in aging HSPCs
Background HSPC (hematopoietic stem/progenitor cell) aging was closely associated with the organism aging, senile diseases and hematopoietic related diseases. Therefore, study on HSPC aging is of great significance to further elucidate the mechanisms of aging and to treat hematopoietic disease resulting from HSPC aging. Little attention had been paid to mRNA splicing as a mechanism underlying HSPC senescence. Results We used our lab’s patented in vitro aging model of HSPCs to analyze mRNA splicing relevant protein alterations with iTRAQ-based proteomic analysis. We found that not only the notable mRNA splicing genes such as SR, hnRNP, WBP11, Sf3b1, Ptbp1 and U2AF1 but also the scarcely reported mRNA splicing relevant genes such as Rbmxl1, Dhx16, Pcbp2, Pabpc1 were significantly down-regulated. We further verified their gene expressions by qRT-PCR. In addition, we reported the effect of Spliceostatin A (SSA), which inhibits mRNA splicing in vivo and in vitro, on HSPC aging. Conclusions It was concluded that mRNA splicing emerged as an important factor for the vulnerability of HSPC aging. This study improved our understanding of the role of mRNA splicing in the HSPC aging process.
- Open Access
- 19 December 2019
- Published by Springer Nature in Research Square
Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based proteomic analysis of mRNA splicing relevant proteins in aging HSPCs
Background: HSPC aging was closely associated with the organism aging, senile diseases and hematopoietic related diseases. Therefore, study on HSPC aging born great significance to further elucidate the mechanisms of aging and to treat hematopoietic disease resulted from HSPC aging. Little attention had been paid to mRNA splicing as a mechanism underlying HSPC senescence. Results: We used our lab’s patented aging model of HSPCs in vitro to analyze mRNA splicing relevant proteins alterations with iTRAQ based proteomic analysis. We found that not only the notable mRNA splicing genes such as SR, hnRNP, WBP11, Sf3b1, Ptbp1 and U2AF1 but also the scarcely reported mRNA splicing relavant genes such as Rbmxl1, Dhx16, Pcbp2, Pabpc1 were significantly down-regulated. We further verified their genes expressions by qRT-PCR. In addition, we reported the effect of Spliceostatin A (SSA), which inhibits mRNA splicing in vivo and in vitro, on HSPC aging. Conclusions: It was concluded that mRNA splicing emerged as an important vulnerability of HSPC aging. This study improved our understanding of the role of mRNA splicing in the HSPC aging process.
- 19 December 2019
- Published by Springer Nature in Research Square
Open AccessIsobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based proteomic analysis of mRNA splicing relevant proteins in aging HSPCs
Background: HSPC aging was closely associated with the organism aging, senile diseases and hematopoietic related diseases. Therefore, study on HSPC aging born great significance to further elucidate the mechanisms of aging and to treat hematopoietic disease resulted from HSPC aging. Little attention had been paid to mRNA splicing as a mechanism underlying HSPC senescence. Results: We used our lab’s patented aging model of HSPCs in vitro to analyze mRNA splicing relevant proteins alterations with iTRAQ based proteomic analysis. We found that not only the notable mRNA splicing genes such as SR, hnRNP, WBP11, Sf3b1, Ptbp1 and U2AF1 but also the scarcely reported mRNA splicing relavant genes such as Rbmxl1, Dhx16, Pcbp2, Pabpc1 were significantly down-regulated. We further verified their genes expressions by qRT-PCR. In addition, we reported the effect of Spliceostatin A (SSA), which inhibits mRNA splicing in vivo and in vitro, on HSPC aging. Conclusions: It was concluded that mRNA splicing emerged as an important vulnerability of HSPC aging. This study improved our understanding of the role of mRNA splicing in the HSPC aging process.
- 25 February 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (7) , 11401-11408
RNA‐Seq analysis of differentially expressed genes relevant to mismatch repair in aging hematopoietic stem‐progenitor cells
We used RNA‐sequencing (RNA‐Seq) technology and an old hematopoietic stem and progenitor cells (HSPCs) model in vitro to analyze differential expressions of mismatch repair (MMR)‐related genes in aged HSPCs, so as to explore the mechanism of DNA MMR injury in hematopoietic stem cells (HSC) aging. In this study, by combining RNA‐seq data and National Center for Biotechnology Information database, we focus on six widely reported MMR genes MSH2, MSH3, MSH6, MLH1, PMS1, PMS2, and five MMR genes with closer ties to HSC aging Pcna, Exo1, Rpa1, Rpa2, and Rpa3 according to the genes functional classification and the related signaling pathway. It is concluded that MMR is closely related to HSC aging. This study provides experimental evidence for future researching MMR in HSC aging.
- 25 February 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (7) , 11401-11408
RNA‐Seq analysis of differentially expressed genes relevant to mismatch repair in aging hematopoietic stem‐progenitor cells
We used RNA‐sequencing (RNA‐Seq) technology and an old hematopoietic stem and progenitor cells (HSPCs) model in vitro to analyze differential expressions of mismatch repair (MMR)‐related genes in aged HSPCs, so as to explore the mechanism of DNA MMR injury in hematopoietic stem cells (HSC) aging. In this study, by combining RNA‐seq data and National Center for Biotechnology Information database, we focus on six widely reported MMR genes MSH2, MSH3, MSH6, MLH1, PMS1, PMS2, and five MMR genes with closer ties to HSC aging Pcna, Exo1, Rpa1, Rpa2, and Rpa3 according to the genes functional classification and the related signaling pathway. It is concluded that MMR is closely related to HSC aging. This study provides experimental evidence for future researching MMR in HSC aging.
- Open Access
In Vitro Neuroprotection of Rat Hippocampal Neurons by Manninotriose and Astragaloside IV Against Corticosterone-Induced Toxicity
A chronically elevated glucocorticoid level impairs memory and cognition. Manninotriose is the main oligosaccharide of Prepared Radix Rehmanniae, and Astragaloside IV (AS-IV) is the primary ingredient of Astragali Radix; they have been reported to possess neuroprotective effects. The aim of the present study was to investigate the protective effects of Manninotriose and AS-IV on corticosterone (CORT) induced neurotoxicity and the underlying mechanisms. Primary cultured hippocampal neurons from newborn Sprague Dawley rats were treated with CORT in the absence or presence of Manninotriose and AS-IV. Cell Counting Kit-8 experiments and fluorescein diacetate (FDA)/propidium iodide (PI) double staining were conducted to assess the activity and survival rate of neurons. Quantitative Real-time PCR (qRT-PCR) and western blot analysis were performed to detect the expression of glucocorticoid receptor (GR), zinc finger protein (Zif268) and synapsin 1 (SYN1). DNA methylation of the gene promoter was assessed by bisulfite sequencing (BSP) analysis. The results demonstrated that pre-treatment with Manninotriose and AS-IV significantly improved cell viability and survival rate, and ameliorated the downregulation of GR, Zif268 and SYN1 genes in CORT injured neurons. BSP analysis revealed that CORT was able to improve the CpG island methylation rate of SYN1. AS-IV was observed to decrease the hypermethylation of the SYN1 gene induced by CORT. The results of the present study indicated that Manninotriose and AS-IV may have a protective effect against CORT-induced damage and the downregulation of learning and memory associated genes in hippocampal neurons. Regulation of DNA methylation may be important in the pharmaceutical activities of AS-IV. Thus, Manninotriose and AS-IV may be effective agents against learning and memory impairment.
Open AccessIn Vitro Neuroprotection of Rat Hippocampal Neurons by Manninotriose and Astragaloside IV Against Corticosterone-Induced Toxicity
A chronically elevated glucocorticoid level impairs memory and cognition. Manninotriose is the main oligosaccharide of Prepared Radix Rehmanniae, and Astragaloside IV (AS-IV) is the primary ingredient of Astragali Radix; they have been reported to possess neuroprotective effects. The aim of the present study was to investigate the protective effects of Manninotriose and AS-IV on corticosterone (CORT) induced neurotoxicity and the underlying mechanisms. Primary cultured hippocampal neurons from newborn Sprague Dawley rats were treated with CORT in the absence or presence of Manninotriose and AS-IV. Cell Counting Kit-8 experiments and fluorescein diacetate (FDA)/propidium iodide (PI) double staining were conducted to assess the activity and survival rate of neurons. Quantitative Real-time PCR (qRT-PCR) and western blot analysis were performed to detect the expression of glucocorticoid receptor (GR), zinc finger protein (Zif268) and synapsin 1 (SYN1). DNA methylation of the gene promoter was assessed by bisulfite sequencing (BSP) analysis. The results demonstrated that pre-treatment with Manninotriose and AS-IV significantly improved cell viability and survival rate, and ameliorated the downregulation of GR, Zif268 and SYN1 genes in CORT injured neurons. BSP analysis revealed that CORT was able to improve the CpG island methylation rate of SYN1. AS-IV was observed to decrease the hypermethylation of the SYN1 gene induced by CORT. The results of the present study indicated that Manninotriose and AS-IV may have a protective effect against CORT-induced damage and the downregulation of learning and memory associated genes in hippocampal neurons. Regulation of DNA methylation may be important in the pharmaceutical activities of AS-IV. Thus, Manninotriose and AS-IV may be effective agents against learning and memory impairment.
- Open Access
- 21 February 2018
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 38 (1)
Hematopoietic stem/progenitor cell senescence is associated with altered expression profiles of cellular memory-involved gene
Objective: To evaluate the contributions of cellular memory mechanisms to hematopoietic stem/progenitor cell (HSPC) senescence. Methods: HSPC (Lin-CD117+) were separated from young (6 week-old) and aged (18 month-old) mice using Magnetic Activated Cell Sorting(MACS). Cell cycle distribution of HSPCs was determined using flow cytometry. The colony forming unit (CFU-mix) assay was used to study the HSPC ability to proliferate. The mRNA expression levels of cellular memory-implicated PCG family (Ezh2, Bmi-1, Eed, Mel18, Mph1/Rae-28) and TrxG family (Mll, Trx) were determined by Quantitative Real-time PCR. Results: We obtained highly purified populations of mouse HSPCs (Lin-CD117+) (92.2% ± 4.5% CD117+). The percentage of HSPCs was significantly higher in older mice compared to younger control mice and the percentage of SA-β-galactosidase positive cells was significantly higher in HSPCs isolated from older mice (P Conclusion: The expression of genes associated with cellular memory is altered in senescent (Lin- CD117+) HSPCs, which may affect the potential plasticity of aged HSC and thereby contribute to senescence associated disease processes.
- 21 February 2018
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 38 (1)
Open AccessHematopoietic stem/progenitor cell senescence is associated with altered expression profiles of cellular memory-involved gene
Objective: To evaluate the contributions of cellular memory mechanisms to hematopoietic stem/progenitor cell (HSPC) senescence. Methods: HSPC (Lin-CD117+) were separated from young (6 week-old) and aged (18 month-old) mice using Magnetic Activated Cell Sorting(MACS). Cell cycle distribution of HSPCs was determined using flow cytometry. The colony forming unit (CFU-mix) assay was used to study the HSPC ability to proliferate. The mRNA expression levels of cellular memory-implicated PCG family (Ezh2, Bmi-1, Eed, Mel18, Mph1/Rae-28) and TrxG family (Mll, Trx) were determined by Quantitative Real-time PCR. Results: We obtained highly purified populations of mouse HSPCs (Lin-CD117+) (92.2% ± 4.5% CD117+). The percentage of HSPCs was significantly higher in older mice compared to younger control mice and the percentage of SA-β-galactosidase positive cells was significantly higher in HSPCs isolated from older mice (P Conclusion: The expression of genes associated with cellular memory is altered in senescent (Lin- CD117+) HSPCs, which may affect the potential plasticity of aged HSC and thereby contribute to senescence associated disease processes.